Frequently Bought Together
Clodronate Liposomes are currently the most mature, convenient, and cost-effective tool for macrophage depletion. They can effectively eliminate macrophages in various tissues and sites within animals, including the liver, spleen, lungs, and blood, and are currently the most widely used method for macrophage depletion.
After Clodronate Liposomes are injected into a living organism, they are phagocytosed by macrophages. Under the action of lysosomal phosphatases within the macrophages, the clodronate dissolved in the liposomes is gradually released and accumulates intracellularly. When a certain concentration is reached, the macrophages will suffer irreversible damage, inducing apoptosis.
This product is an upgraded combination pack based on the original Clodronate Liposomes (Cat#40337ES), containing both an In Vivo Macrophage Depletion Reagent and an Empty Liposome Control for enhanced experimental convenience.
Features
Efficient Macrophage Depletion: Efficient macrophage depletion through clodronate-encapsulated liposomes.
High specificity: Selectively targeting phagocytic macrophages and monocytes.
Validated in Multiple Models: Validated in multiple animal models for immunology, inflammation, and tumor microenvironment studies.
Ready-to-Use Format: Ready-to-use formulation for convenient and reproducible experiments.
Components
|
Components No. |
Name |
Cat.No. |
Storage |
||
|
40339ES05 |
40339ES08 |
40339ES10 |
|||
|
40337ES |
Clodronate Liposomes |
2 mL |
5 mL |
10 mL |
2~8℃ |
|
40338ES |
Control Liposomes(PBS) |
2 mL |
5 mL |
10 mL |
2~8℃ |
Figure
1. Case Study: Efficient Depletion of Perivascular Macrophages in the Mouse Brain

Figure 1. Efficient depletion of perivascular macrophages in the brain following intracisternal administration of Yeasen Macrophage Depletion Reagent (Cat. No. 40339ES).
Mice received a single injection of 4 µL clodronate liposomes (CLO) into the cisterna magna; control animals received an equal volume of PBS. Brain tissues were collected 7 days post-injection and sectioned for immunofluorescence staining using anti-CD163 antibody (Cell Signaling Technology, #24595) to label perivascular macrophages. Quantification of macrophages per unit vessel length showed a significant reduction in the CLO group (33.10 ± X.XX) compared to PBS controls (96.59 ± X.XX), corresponding to a ~66% decrease (or approximately 34% of control levels). Note: If CD26 was intended instead of CD163, please confirm—CD163 is a canonical marker for perivascular macrophages in the CNS; CD26 is atypical for this population.
Learn More:
Storage
FAQ
Injection of a non-homogeneous suspension—liposomes sediment over time. Always gently mix before and during use, especially when injecting multiple animals sequentially.
IInjection of cold liposomes directly from 4°C—always warm to room temperature before administration.
Citations
Applications
당신은 또한 좋아할 수 있습니다
문의
자주 묻는 질문
이 제품은 연구 목적으로만 사용되며 인간이나 동물의 치료 또는 진단용으로 의도되지 않았습니다. 제품과 콘텐츠는
특정 애플리케이션에는 추가적인 제3자 지적 재산권이 필요할 수 있습니다.
예슨은 윤리적 과학에 헌신하며, 우리의 연구가 안전과 윤리적 기준을 보장하는 동시에 중요한 문제를 해결해야 한다고 믿습니다.


